Drug intelligence / Profile preview

Xinqi

Development stage
Unknown
Lead developer
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Xinqi is a Traditional Chinese Medicine (TCM) herbal preparation developed by Dongzhimen Hospital, affiliated with the Beijing University of Chinese Medicine, specifically for the treatment of allergic rhinitis (AR). The formula is primarily composed of *Magnolia biondii* (Xin Yi) and *Astragalus membranaceus* (Huang Qi), designed to address the TCM patterns of 'Lung-Qi deficiency' and 'Wind-Cold' attacking the nose. Mechanistically, Xinqi acts as an immunomodulator that restores the balance between Th1 and Th2 immune responses. Clinical and pharmacological studies indicate that it reduces the levels of allergen-specific IgE and pro-inflammatory cytokines such as IL-4 and IL-13, while increasing the expression of IFN-gamma. This shift in the cytokine profile helps suppress the allergic inflammatory cascade in the nasal mucosa, thereby alleviating symptoms such as sneezing, nasal itching, and rhinorrhea.

Brand names
Xinqi Granules
Other names
Xinqi FormulaXinqi FangXinqi Keli辛芪颗粒辛芪方
02

Targets

IL-4 (Interleukin 4)IFNG (Interferon gamma)IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Xinqi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinqi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call